Pharmacist phone calls could boost lifesaving statin use in heart patients
NCT ID NCT06551701
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This study tests whether having a pharmacist call both patients with heart disease and their doctors can increase the use of high-intensity statins—powerful cholesterol-lowering drugs that prevent future heart problems. The trial includes adults aged 18 to 75 with atherosclerotic cardiovascular disease who are not already on a moderate or high-intensity statin. The goal is to see if this simple, low-cost intervention can improve medication use and reduce the risk of heart attacks and strokes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
pharmacist-led intervention (calls to patients and providers)
What this could lead to
If successful, this approach could help more patients with heart disease get the recommended statin therapy, potentially reducing heart attacks and strokes.
What could go wrong
This is a small, early-stage trial focused on feasibility, not on directly measuring health outcomes. The intervention may not change prescribing habits or improve patient health.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASCVD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Carelon Research
Wilmington, Delaware, 19801, United States
-
Duke Clinical Research Institute
Durham, North Carolina, 27701, United States